Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012

Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy

(2012) K.E. Wiley et al.   VACCINE

Pertussis Serodiagnosis in Belgium from 1990 to 2009

(2011) Muriel Vincent et al.   Clinical and Vaccine Immunology

Rationale for pertussis booster vaccination throughout life in Europe

(2011) Fred Zepp et al.   LANCET INFECTIOUS DISEASES

Vaccinate the Village

(2010) Alfred DeMaria Jr et al.   CLINICAL INFECTIOUS DISEASES

Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium

(2010) H. THEETEN et al.   EPIDEMIOLOGY AND INFECTION

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

(2010) Sabine C. de Greeff et al.   PLoS One

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination withBordetella pertussisin young children

(2009) HANS O. HALLANDER et al.   APMIS

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content

(2009) Lotte H. Hendrikx et al.   VACCINE